26 May 2013
Keywords: athena, zelapar, launched, uk, neurosciences, 25mg, selegiline
Article | 09 December 1998
Athena Neurosciences' Zelapar 1.25mg (selegiline hydrochloride), anew formulation with a novel delivery system designed to reduce unnecessary l-amphetamine metabolites has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.